CAP-100
Product Specifications
Target
CCR
Related Pathways
GPCR/G Protein|||Microbiology/Virology|||Immunology/Inflammation
Bioactivity
CAP-100 is a monoclonal antibody targeting CCR7. It neutralizes the ligand binding site and signaling of CCR7. This compound effectively inhibits migration, extravasation, homing, and survival in chronic lymphocytic leukemia (CLL) samples induced by CCR7. CAP-100 can mediate potent tumor cell killing through host immune mechanisms and exhibits favorable toxicity profiles in related hematopoietic cell subsets. It is involved in research on antitumor activity and diseases like chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/348162812477964324/T9901A-961
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6473949-01 0.2 mL
eNos, NT (Nitric Oxide Synthase, Endothelial, Endothelial NOS, eNOS, EC-NOS, NOS Type III, NOSIII, Constitutive NOS, cNOS, NOS3) (APC)
Ask
View Details 
MBS6473949-02 5x 0.2 mL
eNos, NT (Nitric Oxide Synthase, Endothelial, Endothelial NOS, eNOS, EC-NOS, NOS Type III, NOSIII, Constitutive NOS, cNOS, NOS3) (APC)
Ask
View Details